お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は肝臓疾患の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは肝臓疾患の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の肝臓疾患の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは肝臓疾患の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に肝臓疾患の治療市場を分類しています。本研究に含まれる主な企業は：Abbott Laboratories、Bayer Schering、Eli Lilly、Merck、Novartis、Pfizer、Roche、Sanofi-Aventis、Takeda Pharmaceutical、Zydus Pharmaceuticals、Glaxosmithkline、Bristol-Myers Squibb、General Electric、Koninklijke Philips、Siemens、Canon Medical Systems Corp、Hitachi、Elekta、Neusoft Corporation、Samsung Healthcare、BPL Medical Technologies、Cura Healthcare、Angion Biomedica、Achillion Pharmaceuticals、Gilead Sciences、LG Life Sciences、Verva Pharmaceuticals、Shenzhen Kangtai Biological Products、Raptor Pharmaceuticals、ProMetic Life Sciences、Phenex Pharmaceuticals

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Chemotherapy Drugs
    Targeted Therapy
    Anti-Viral Drugs
    Immunoglobulins
    Corticosteroids
    Vaccines
    Anti-Rejection Drugs/Immunosuppressant

用途別の市場セグメント：
    Cancer
    Hepatitis
    Cirrhosis
    Other

本レポートの詳細内容
世界の肝臓疾患の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、肝臓疾患の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の肝臓疾患の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の肝臓疾患の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、肝臓疾患の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

肝臓疾患の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：肝臓疾患の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：肝臓疾患の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章肝臓疾患の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：肝臓疾患の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：肝臓疾患の治療の主要企業の概要を提供し、製品の説明と仕様、肝臓疾患の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Liver disease, greenish-yellow or greenish-brown skin, often due to intrahepatic cholestasis, intrahepatic or extrahepatic biliary obstruction.The sex hormone secreted in liver disease cannot degrade and inactivate in time, which leads to hyperemia and dilatation of superficial arterioles.
Market Analysis and Insights: Global Liver Diseases Treatment Market
The global Liver Diseases Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Liver Diseases Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Liver Diseases Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Diseases Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liver Diseases Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Liver Diseases Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Liver Diseases Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, Bayer Schering, Eli Lilly, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Takeda Pharmaceutical, etc.

Market Segmentation
By Company
    Abbott Laboratories
    Bayer Schering
    Eli Lilly
    Merck
    Novartis
    Pfizer
    Roche
    Sanofi-Aventis
    Takeda Pharmaceutical
    Zydus Pharmaceuticals
    Glaxosmithkline
    Bristol-Myers Squibb
    General Electric
    Koninklijke Philips
    Siemens
    Canon Medical Systems Corp
    Hitachi
    Elekta
    Neusoft Corporation
    Samsung Healthcare
    BPL Medical Technologies
    Cura Healthcare
    Angion Biomedica
    Achillion Pharmaceuticals
    Gilead Sciences
    LG Life Sciences
    Verva Pharmaceuticals
    Shenzhen Kangtai Biological Products
    Raptor Pharmaceuticals
    ProMetic Life Sciences
    Phenex Pharmaceuticals

Segment by Type
    Chemotherapy Drugs
    Targeted Therapy
    Anti-Viral Drugs
    Immunoglobulins
    Corticosteroids
    Vaccines
    Anti-Rejection Drugs/Immunosuppressant

Segment by Application
    Cancer
    Hepatitis
    Cirrhosis
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Liver Diseases Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Diseases Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Diseases Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Liver Diseases Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chemotherapy Drugs
    Table 3. Key Players of Targeted Therapy
    Table 4. Key Players of Anti-Viral Drugs
    Table 5. Key Players of Immunoglobulins
    Table 6. Key Players of Corticosteroids
    Table 7. Key Players of Vaccines
    Table 8. Key Players of Anti-Rejection Drugs/Immunosuppressant
    Table 9. Global Liver Diseases Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 10. Global Liver Diseases Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Liver Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Liver Diseases Treatment Market Share by Region (2019-2024)
    Table 13. Global Liver Diseases Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Liver Diseases Treatment Market Share by Region (2025-2030)
    Table 15. Liver Diseases Treatment Market Trends
    Table 16. Liver Diseases Treatment Market Drivers
    Table 17. Liver Diseases Treatment Market Challenges
    Table 18. Liver Diseases Treatment Market Restraints
    Table 19. Global Liver Diseases Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Liver Diseases Treatment Revenue Share by Players (2019-2024)
    Table 21. Global Top Liver Diseases Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Treatment as of 2023)
    Table 22. Global Liver Diseases Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 23. Global 5 Largest Players Market Share by Liver Diseases Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Global Key Players of Liver Diseases Treatment, Headquarters and Area Served
    Table 25. Global Key Players of Liver Diseases Treatment, Product and Application
    Table 26. Global Key Players of Liver Diseases Treatment, Product and Application
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Liver Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Liver Diseases Treatment Revenue Market Share by Type (2019-2024)
    Table 30. Global Liver Diseases Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Liver Diseases Treatment Revenue Market Share by Type (2025-2030)
    Table 32. Global Liver Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Liver Diseases Treatment Revenue Share by Application (2019-2024)
    Table 34. Global Liver Diseases Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Liver Diseases Treatment Revenue Share by Application (2025-2030)
    Table 36. North America Liver Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 37. North America Liver Diseases Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 38. North America Liver Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 39. North America Liver Diseases Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 40. North America Liver Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. North America Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 42. North America Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Europe Liver Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 44. Europe Liver Diseases Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 45. Europe Liver Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 46. Europe Liver Diseases Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 47. Europe Liver Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Europe Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Europe Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 50. China Liver Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 51. China Liver Diseases Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 52. China Liver Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 53. China Liver Diseases Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Liver Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 55. Asia Liver Diseases Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 56. Asia Liver Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 57. Asia Liver Diseases Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 58. Asia Liver Diseases Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 59. Asia Liver Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 60. Asia Liver Diseases Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Liver Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Liver Diseases Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Liver Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Liver Diseases Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Liver Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 66. Middle East, Africa, and Latin America Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 68. Abbott Laboratories Company Details
    Table 69. Abbott Laboratories Business Overview
    Table 70. Abbott Laboratories Liver Diseases Treatment Product
    Table 71. Abbott Laboratories Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 72. Abbott Laboratories Recent Developments
    Table 73. Bayer Schering Company Details
    Table 74. Bayer Schering Business Overview
    Table 75. Bayer Schering Liver Diseases Treatment Product
    Table 76. Bayer Schering Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 77. Bayer Schering Recent Developments
    Table 78. Eli Lilly Company Details
    Table 79. Eli Lilly Business Overview
    Table 80. Eli Lilly Liver Diseases Treatment Product
    Table 81. Eli Lilly Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 82. Eli Lilly Recent Developments
    Table 83. Merck Company Details
    Table 84. Merck Business Overview
    Table 85. Merck Liver Diseases Treatment Product
    Table 86. Merck Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 87. Merck Recent Developments
    Table 88. Novartis Company Details
    Table 89. Novartis Business Overview
    Table 90. Novartis Liver Diseases Treatment Product
    Table 91. Novartis Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 92. Novartis Recent Developments
    Table 93. Pfizer Company Details
    Table 94. Pfizer Business Overview
    Table 95. Pfizer Liver Diseases Treatment Product
    Table 96. Pfizer Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 97. Pfizer Recent Developments
    Table 98. Roche Company Details
    Table 99. Roche Business Overview
    Table 100. Roche Liver Diseases Treatment Product
    Table 101. Roche Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 102. Roche Recent Developments
    Table 103. Sanofi-Aventis Company Details
    Table 104. Sanofi-Aventis Business Overview
    Table 105. Sanofi-Aventis Liver Diseases Treatment Product
    Table 106. Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 107. Sanofi-Aventis Recent Developments
    Table 108. Takeda Pharmaceutical Company Details
    Table 109. Takeda Pharmaceutical Business Overview
    Table 110. Takeda Pharmaceutical Liver Diseases Treatment Product
    Table 111. Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 112. Takeda Pharmaceutical Recent Developments
    Table 113. Zydus Pharmaceuticals Company Details
    Table 114. Zydus Pharmaceuticals Business Overview
    Table 115. Zydus Pharmaceuticals Liver Diseases Treatment Product
    Table 116. Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 117. Zydus Pharmaceuticals Recent Developments
    Table 118. Glaxosmithkline Company Details
    Table 119. Glaxosmithkline Business Overview
    Table 120. Glaxosmithkline Liver Diseases Treatment Product
    Table 121. Glaxosmithkline Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 122. Glaxosmithkline Recent Developments
    Table 123. Bristol-Myers Squibb Company Details
    Table 124. Bristol-Myers Squibb Business Overview
    Table 125. Bristol-Myers Squibb Liver Diseases Treatment Product
    Table 126. Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 127. Bristol-Myers Squibb Recent Developments
    Table 128. General Electric Company Details
    Table 129. General Electric Business Overview
    Table 130. General Electric Liver Diseases Treatment Product
    Table 131. General Electric Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 132. General Electric Recent Developments
    Table 133. Koninklijke Philips Company Details
    Table 134. Koninklijke Philips Business Overview
    Table 135. Koninklijke Philips Liver Diseases Treatment Product
    Table 136. Koninklijke Philips Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 137. Koninklijke Philips Recent Developments
    Table 138. Siemens Company Details
    Table 139. Siemens Business Overview
    Table 140. Siemens Liver Diseases Treatment Product
    Table 141. Siemens Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 142. Siemens Recent Developments
    Table 143. Canon Medical Systems Corp Company Details
    Table 144. Canon Medical Systems Corp Business Overview
    Table 145. Canon Medical Systems Corp Liver Diseases Treatment Product
    Table 146. Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 147. Canon Medical Systems Corp Recent Developments
    Table 148. Hitachi Company Details
    Table 149. Hitachi Business Overview
    Table 150. Hitachi Liver Diseases Treatment Product
    Table 151. Hitachi Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 152. Hitachi Recent Developments
    Table 153. Elekta Company Details
    Table 154. Elekta Business Overview
    Table 155. Elekta Liver Diseases Treatment Product
    Table 156. Elekta Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 157. Elekta Recent Developments
    Table 158. Neusoft Corporation Company Details
    Table 159. Neusoft Corporation Business Overview
    Table 160. Neusoft Corporation Liver Diseases Treatment Product
    Table 161. Neusoft Corporation Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 162. Neusoft Corporation Recent Developments
    Table 163. Samsung Healthcare Company Details
    Table 164. Samsung Healthcare Business Overview
    Table 165. Samsung Healthcare Liver Diseases Treatment Product
    Table 166. Samsung Healthcare Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 167. Samsung Healthcare Recent Developments
    Table 168. BPL Medical Technologies Company Details
    Table 169. BPL Medical Technologies Business Overview
    Table 170. BPL Medical Technologies Liver Diseases Treatment Product
    Table 171. BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 172. BPL Medical Technologies Recent Developments
    Table 173. Cura Healthcare Company Details
    Table 174. Cura Healthcare Business Overview
    Table 175. Cura Healthcare Liver Diseases Treatment Product
    Table 176. Cura Healthcare Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 177. Cura Healthcare Recent Developments
    Table 178. Angion Biomedica Company Details
    Table 179. Angion Biomedica Business Overview
    Table 180. Angion Biomedica Liver Diseases Treatment Product
    Table 181. Angion Biomedica Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 182. Angion Biomedica Recent Developments
    Table 183. Achillion Pharmaceuticals Company Details
    Table 184. Achillion Pharmaceuticals Business Overview
    Table 185. Achillion Pharmaceuticals Liver Diseases Treatment Product
    Table 186. Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 187. Achillion Pharmaceuticals Recent Developments
    Table 188. Gilead Sciences Company Details
    Table 189. Gilead Sciences Business Overview
    Table 190. Gilead Sciences Liver Diseases Treatment Product
    Table 191. Gilead Sciences Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 192. Gilead Sciences Recent Developments
    Table 193. LG Life Sciences Company Details
    Table 194. LG Life Sciences Business Overview
    Table 195. LG Life Sciences Liver Diseases Treatment Product
    Table 196. LG Life Sciences Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 197. LG Life Sciences Recent Developments
    Table 198. Verva Pharmaceuticals Company Details
    Table 199. Verva Pharmaceuticals Business Overview
    Table 200. Verva Pharmaceuticals Liver Diseases Treatment Product
    Table 201. Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 202. Verva Pharmaceuticals Recent Developments
    Table 203. Shenzhen Kangtai Biological Products Company Details
    Table 204. Shenzhen Kangtai Biological Products Business Overview
    Table 205. Shenzhen Kangtai Biological Products Liver Diseases Treatment Product
    Table 206. Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 207. Shenzhen Kangtai Biological Products Recent Developments
    Table 208. Raptor Pharmaceuticals Company Details
    Table 209. Raptor Pharmaceuticals Business Overview
    Table 210. Raptor Pharmaceuticals Liver Diseases Treatment Product
    Table 211. Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 212. Raptor Pharmaceuticals Recent Developments
    Table 213. ProMetic Life Sciences Company Details
    Table 214. ProMetic Life Sciences Business Overview
    Table 215. ProMetic Life Sciences Liver Diseases Treatment Product
    Table 216. ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 217. ProMetic Life Sciences Recent Developments
    Table 218. Phenex Pharmaceuticals Company Details
    Table 219. Phenex Pharmaceuticals Business Overview
    Table 220. Phenex Pharmaceuticals Liver Diseases Treatment Product
    Table 221. Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
    Table 222. Phenex Pharmaceuticals Recent Developments
    Table 223. Research Programs/Design for This Report
    Table 224. Key Data Information from Secondary Sources
    Table 225. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Liver Diseases Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Liver Diseases Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Chemotherapy Drugs Features
    Figure 4. Targeted Therapy Features
    Figure 5. Anti-Viral Drugs Features
    Figure 6. Immunoglobulins Features
    Figure 7. Corticosteroids Features
    Figure 8. Vaccines Features
    Figure 9. Anti-Rejection Drugs/Immunosuppressant Features
    Figure 10. Global Liver Diseases Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Liver Diseases Treatment Market Share by Application: 2023 VS 2030
    Figure 12. Cancer Case Studies
    Figure 13. Hepatitis Case Studies
    Figure 14. Cirrhosis Case Studies
    Figure 15. Other Case Studies
    Figure 16. Liver Diseases Treatment Report Years Considered
    Figure 17. Global Liver Diseases Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Liver Diseases Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Liver Diseases Treatment Market Share by Region: 2023 VS 2030
    Figure 20. Global Liver Diseases Treatment Market Share by Players in 2023
    Figure 21. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Treatment as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Liver Diseases Treatment Revenue in 2023
    Figure 23. North America Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Liver Diseases Treatment Market Share by Type (2019-2030)
    Figure 25. North America Liver Diseases Treatment Market Share by Application (2019-2030)
    Figure 26. North America Liver Diseases Treatment Market Share by Country (2019-2030)
    Figure 27. United States Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Liver Diseases Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Liver Diseases Treatment Market Share by Type (2019-2030)
    Figure 31. Europe Liver Diseases Treatment Market Share by Application (2019-2030)
    Figure 32. Europe Liver Diseases Treatment Market Share by Country (2019-2030)
    Figure 33. Germany Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Liver Diseases Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Liver Diseases Treatment Market Share by Type (2019-2030)
    Figure 41. China Liver Diseases Treatment Market Share by Application (2019-2030)
    Figure 42. Asia Liver Diseases Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Liver Diseases Treatment Market Share by Type (2019-2030)
    Figure 44. Asia Liver Diseases Treatment Market Share by Application (2019-2030)
    Figure 45. Asia Liver Diseases Treatment Market Share by Region (2019-2030)
    Figure 46. Japan Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Liver Diseases Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Liver Diseases Treatment Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Liver Diseases Treatment Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Liver Diseases Treatment Market Share by Country (2019-2030)
    Figure 56. Brazil Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Abbott Laboratories Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 63. Bayer Schering Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 64. Eli Lilly Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 65. Merck Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 66. Novartis Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 67. Pfizer Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 68. Roche Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 69. Sanofi-Aventis Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 70. Takeda Pharmaceutical Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 71. Zydus Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 72. Glaxosmithkline Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 73. Bristol-Myers Squibb Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 74. General Electric Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 75. Koninklijke Philips Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 76. Siemens Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 77. Canon Medical Systems Corp Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 78. Hitachi Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 79. Elekta Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 80. Neusoft Corporation Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 81. Samsung Healthcare Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 82. BPL Medical Technologies Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 83. Cura Healthcare Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 84. Angion Biomedica Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 85. Achillion Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 86. Gilead Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 87. LG Life Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 88. Verva Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 89. Shenzhen Kangtai Biological Products Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 90. Raptor Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 91. ProMetic Life Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 92. Phenex Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed